Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Shu-Feng Zhou, Bo Wang, Li-Ping Yang & Jun-Ping Liu. (2010) Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metabolism Reviews 42:2, pages 268-354.
Read now
Read now
William W. Johnson. (2008) Cytochrome P450 Inactivation by Pharmaceuticals and Phytochemicals: Therapeutic Relevance. Drug Metabolism Reviews 40:1, pages 101-147.
Read now
Read now
A. Nakashima, H. Kawashita, N. Masuda, C. Saxer, M. Niina, Y. Nagae & K. Iwasaki. (2005) Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica 35:6, pages 589-602.
Read now
Read now
D. F. V. Lewis, B. G. Lake, M. Dickins, Y.-F. Ueng & P. S. Goldfarb. (2003) Homology modelling of human CYP1A2 based on the CYP2C5 crystallographic template structure. Xenobiotica 33:3, pages 239-254.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
V. Subrahmanyam, A. B. Renwick, D. G. Walters, R. J. Price, A. P. Tonelli & B. G. Lake. (2002) Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Xenobiotica 32:6, pages 521-534.
Read now
Read now
M. S. Ching, C. L. Blake, N. A. Malek, P. W. Angus & H. Ghabrial. (2001) Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine. Xenobiotica 31:11, pages 757-767.
Read now
Read now
A. B. Renwick, D. Surry, R. J. Price, B. G. Lake & D. C. Evans. (2000) Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms. Xenobiotica 30:10, pages 955-969.
Read now
Read now
N. Ishiguro, C. Senda, W. Kishimoto, K. Sakai, Y. Funae, T. Igarashi. (2000) Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes. Xenobiotica 30:1, pages 71-80.
Read now
Read now
G. C. MOODY. (1999) Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. Xenobiotica 29:1, pages 53-75.
Read now
Read now
R. AZUMA, M. KOMURO, B. H. KORSCH, J. C. ANDRE, O. ONNAGAWA, S. R. BLACK & J. M. MATHEWS. (1999) Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease. Xenobiotica 29:7, pages 747-762.
Read now
Read now
A. B. RENWICK, H. MISTRY, S. E. BALL, D. G. WALTERS, J. KAO & B. G. LAKE. (1998) Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica 28:4, pages 337-348.
Read now
Read now
O. PELKONEN, J. MÄEENPÄEÄ, P. TAAVITSAINEN, A. RAUTIO & H. RAUNIO. (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:12, pages 1203-1253.
Read now
Read now
S. E. CLARKE. (1998) In vitro assessment of human cytochrome P450. Xenobiotica 28:12, pages 1167-1202.
Read now
Read now
D. A. SMITH, S. M. ABEL, R. HYLAND & B. C. JONES. (1998) Human cytochrome P450s: selectivity and measurement in vivo. Xenobiotica 28:12, pages 1095-1128.
Read now
Read now
S. J. Baldwin, J. C. Bloomer, G. J. Smith, A. D. Ayrton, S. E. Clarke & R. J. Chenery. (1995) Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25:3, pages 261-270.
Read now
Read now
J. C. Bloomer, S. E. Clarke & R. J. Chenery. (1995) Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeine. Xenobiotica 25:9, pages 917-927.
Read now
Read now
Articles from other publishers (39)
Guangyun Ran, Yufen Liao, Xin Wang, Ying Liu, Bowen Gong, Chutian Wu, Zihao Cheng, Ying Peng, Weiwei Li & Jiang Zheng. (2023) Mechanistic Study of Xanthotoxin-Mediated Inactivation of CYP1A2 and Related Drug–Drug Interaction with Tacrine. Chemical Research in Toxicology 36:3, pages 420-429.
Crossref
Crossref
Gracia M. Amaya, Rebecca Durandis, David S. Bourgeois, James A. Perkins, Arsany A. Abouda, Kahari J. Wines, Mohamed Mohamud, Samuel A. Starks, R. Nathan Daniels & Klarissa D. Jackson. (2018) Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib. Chemical Research in Toxicology 31:7, pages 570-584.
Crossref
Crossref
Line Marie Nielsen, Niels Bjerre Holm, Sebastian Leth-Petersen, Jesper Langgaard Kristensen, Lars Olsen & Kristian Linnet. (2017) Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Testing and Analysis 9:5, pages 671-679.
Crossref
Crossref
Line Marie Nielsen, Niels Bjerre Holm, Lars Olsen & Kristian Linnet. (2016) Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11. Drug Testing and Analysis 8:8, pages 792-800.
Crossref
Crossref
Jianmei Wu, Jiajiu Shaw, Sarah Dubaisi, Frederick Valeriote & Jing Li. (2014) In Vitro Metabolism and Drug-Drug Interaction Potential of UTL-5g, a Novel Chemo- and Radioprotective Agent. Drug Metabolism and Disposition 42:12, pages 2058-2067.
Crossref
Crossref
Khaled M. Abass. (2013) From in vitro hepatic metabolic studies towards human health risk assessment: Two case studies of diuron and carbosulfan. Pesticide Biochemistry and Physiology 107:2, pages 258-265.
Crossref
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
111
158
.
Rong Shi, Hui Zhou, Bingliang Ma, Yueming Ma, Dazheng Wu, Xinhong Wang, Hongfeng Luo & Nengneng Cheng. (2012) Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate. Biopharmaceutics & Drug Disposition 33:3, pages 135-145.
Crossref
Crossref
Ah-Young Kang, Lindsay R. Young, Carlus Dingfelder & Sabrina Peterson. (2011) Effects of Furanocoumarins from Apiaceous Vegetables on the Catalytic Activity of Recombinant Human Cytochrome P-450 1A2. The Protein Journal 30:7, pages 447-456.
Crossref
Crossref
Anders Sonesson & Birgitte Buur Rasmussen. (2011) In Vitro Studies Investigating the Interactions between Degarelix, a Decapeptide Gonadotropin-Releasing Hormone Blocker, and Cytochrome P450. Basic & Clinical Pharmacology & Toxicology 109:3, pages 195-202.
Crossref
Crossref
Siamak Cyrus Khojasteh, Saileta Prabhu, Jane R. Kenny, Jason S. Halladay & Anthony Y. H. Lu. (2011) Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. European Journal of Drug Metabolism and Pharmacokinetics 36:1, pages 1-16.
Crossref
Crossref
Takeshi Shimizudani, Kenjiro Nagaoka, Nobumitsu Hanioka, Shigeru Yamano & Shizuo Narimatsu. (2010) Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys. Chemico-Biological Interactions 183:1, pages 67-78.
Crossref
Crossref
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
Ben-Fillippo Krippendorff, Roland Neuhaus, Philip Lienau, Andreas Reichel & Wilhelm Huisinga. (2009) Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values. SLAS Discovery 14:8, pages 913-923.
Crossref
Crossref
Jacek Wójcikowski & Władysława A. Daniel. (2009) Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism – an in vitro study. Pharmacological Reports 61:5, pages 851-858.
Crossref
Crossref
Michael Zientek, Howard Miller, Danielle Smith, Mary Beth Dunklee, Lance Heinle, Archie Thurston, Caroline Lee, Ruth Hyland, Odette Fahmi & Douglas Burdette. (2008) Development of an in vitro drug–drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds. Journal of Pharmacological and Toxicological Methods 58:3, pages 206-214.
Crossref
Crossref
Olavi Pelkonen, Miia Turpeinen, Jukka Hakkola, Paavo Honkakoski, Janne Hukkanen & Hannu Raunio. (2008) Inhibition and induction of human cytochrome P450 enzymes: current status. Archives of Toxicology 82:10, pages 667-715.
Crossref
Crossref
Timothy W. Harper & Patrick J. Brassil. (2008) Reaction Phenotyping: Current Industry Efforts to Identify Enzymes Responsible for Metabolizing Drug Candidates. The AAPS Journal 10:1, pages 200-207.
Crossref
Crossref
Heng-Keang Lim, Nicholas DuczakJr.Jr., Linda Brougham, Michael Elliot, Krupa Patel & Kelvin Chan. (2005) AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition 33:8, pages 1211-1219.
Crossref
Crossref
Maria Almira Correia & Paul R. Ortiz de Montellano. 2005. Cytochrome P450. Cytochrome P450
247
322
.
Yoichi Naritomi, Yuriko Teramura, Shigeyuki Terashita & Akira Kagayama. (2004) Utility of Microtiter Plate Assays for Human Cytochrome P450 Inhibition Studies in Drug Discovery: Application of Simple Method for Detecting Quasi-irreversible and Irreversible Inhibitors. Drug Metabolism and Pharmacokinetics 19:1, pages 55-61.
Crossref
Crossref
Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou & A. David Rodrigues. (2003) MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR. Drug Metabolism and Disposition 31:11, pages 1352-1360.
Crossref
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
Yoko Otake & Thomas Walle. (2002) Oxidation of the Flavonoids Galangin and Kaempferide by Human Liver Microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metabolism and Disposition 30:2, pages 103-105.
Crossref
Crossref
Stephen Clarke & Barry Jones. 2001. Drug-Drug Interactions. Drug-Drug Interactions
55
88
.
David F.V. Lewis, Brian G. Lake, Stephen G. George, Maurice Dickins, Peter J. Eddershaw, Michael H. Tarbit, Alan P. Beresford, Peter S. Goldfarb & F.Peter Guengerich. (1999) Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology 139:1-2, pages 53-79.
Crossref
Crossref
Baldwin, Clarke & Chenery. (1999)
Characterization of the cytochrome P450 enzymes involved in the
in vitro
metabolism of rosiglitazone
. British Journal of Clinical Pharmacology 48:3, pages 424-432.
Crossref
Crossref
Keke Hu & Nigel J. Bunce. (1999) Metabolism of polychlorinated dibenzo-p-dioxins by rat liver microsomes. Journal of Biochemical and Molecular Toxicology 13:6, pages 307-315.
Crossref
Crossref
M. NakajimaK. KobayashiN. ShimadaS. Tokudome, T. YamamotoY. Kuroiwa. (2002) Involvement of CYP1A2 in mexiletine metabolism. British Journal of Clinical Pharmacology 46:1, pages 55-62.
Crossref
Crossref
P.R Tiller, A.P Land, I Jardine, D.M Murphy, R Sozio, A Ayrton & W.H Schaefer. (1998) Application of liquid chromatography–mass spectrometryn analyses to the characterization of novel glyburide metabolites formed in vitro. Journal of Chromatography A 794:1-2, pages 15-25.
Crossref
Crossref
Michael Murray. (2007) DRUG‐MEDIATED INACTIVATION OF CYTOCHROME P450. Clinical and Experimental Pharmacology and Physiology 24:7, pages 465-470.
Crossref
Crossref
Aleksandra Pastrakuljic, Bing K. Tang, Eve A. Roberts & Wemer Kalow. (1997) Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochemical Pharmacology 53:4, pages 531-538.
Crossref
Crossref
H.Kim Crewe, S.Wynne Ellis, Martin S. Lennard & Geoffrey T. Tucker. (1997) Variable contribution of cytochromes p450 2d6, 2c9 and 3a4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochemical Pharmacology 53:2, pages 171-178.
Crossref
Crossref
Thomas G. Schulz, Diether Neubert, Donald S. Davies & Robert J. Edwards. (1996) Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus). Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1298:1, pages 131-140.
Crossref
Crossref
Alan R. Boobis, Nigel J. Gooderham, Robert J. Edwards, Stephen Murray, Anthony M. Lynch, Masoud Yadollahi-Farsani & Donald S. Davies. 1996. Toxicology - From Cells to Man. Toxicology - From Cells to Man
286
302
.
Y. Amet, F. Berthou, S. Baird, Y. Dreano, J.P. Bail & J.F. Menez. (1995) Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochemical Pharmacology 50:11, pages 1775-1782.
Crossref
Crossref
Charles L. Crespi. 1995. Advances in Drug Research Volume 26. Advances in Drug Research Volume 26
179
235
.
Paul R. Ortiz de Montellano & Maria Almira Correia. 1995. Cytochrome P450. Cytochrome P450
305
364
.
JC Bloomer, SJ Baldwin, GJ Smith, AD Ayrton, SE Clarke & RJ Chenery. (2012) Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.. British Journal of Clinical Pharmacology 38:6, pages 557-566.
Crossref
Crossref